A Phase 3 interventional study of Chlorhexidine gluconate 0.2% and Plain water in Dysphagia and Peristomal Wound Infection, sponsored by Hillel Yaffe Medical Center. Status unknown. Open to participants aged 45 Years to 80 Years. Per ClinicalTrials.gov, last updated 2009-03-11.
Sponsored by Hillel Yaffe Medical Center · Phase 3, Interventional, and Prevention
Percutaneous endoscopic gastrostomy (PEG) is commonly used for long term enteral feeding of patients with severe dysphagia. The most common complication is peristomal wound infection. The possible mechanism the bacterial from the oral cavity disseminate during the PEG insertion through the stomach to the abdominal wall, in spite the routine use of antibiotic prophylaxis, have reported low rates of wound infection in patients who were already receiving antibiotics at the time of PEG Our hypothesis that washing the oral cavity with antibiotic solution prior the insertion PEG , We planned a prospective, randomised, double blind, one centre study of antibiotic mouth wash solution (0.2% Chlorhexidine gluconate) as.prophylaxis in PEG
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's planned enrollment of 50 is below the median of 120 across 4,200 interventional studies indexed under Infections.
Browse Infections studies →Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Chlorhexidine gluconate 0.2%
Other: Plain water
Mouth wash prior to procedure
Mouth wash prior to procedure
Assess impact mouth wash (containing 0.2% Chlorhexidine gluconate) (Taro Pharmaceutical Industries Haifa Israel) prior PEG insertion.
Time frame: One month
Follow the peristomal wound infection in patients who had prepared by mouth wash to a group a patients without mouth washing.
Time frame: One month
No study locations are listed for this record.
This study is status unknown, as verified in Mar 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hillel Yaffe Medical Center